CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
da Vinci® Robotic Surgical System +3 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02274493
NCT02274493N/ACompleted

Pilot Study of Robotic-Assisted Harvest of the Latissimus Dorsi Muscles

M.D. Anderson Cancer Center·interventional·Posted Oct 24, 2014·Updated Mar 26, 2019

In Brief

A clinical study evaluating da Vinci® Robotic Surgical System, LD muscle flap harvest procedure, and 2 other interventions for Other Reconstructive Surgery and 4 related conditions. Completed, enrolled 15 participants across 1 site.

Detailed Summary

The goal of this clinical research study is to learn more about the safety and feasibility of using the Da Vinci Robotic Surgical system in procedures that harvest the latissimus dorsi muscle (a back muscle below your shoulder) for reconstructive procedures.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 24, 2014
Enrollment StartJul 8, 2015
Primary CompletionMar 7, 2018
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 11.7 years ago

Interventions

da Vinci® Robotic Surgical Systemdevice

Da Vinci Robotic Surgical system to be used in procedures that harvest the latissimus dorsi muscle for reconstructive procedures

LD muscle flap harvest procedureprocedure

Latissimus dorsi muscle flap harvest procedure using da Vinci® Robotic Surgical System for use in reconstructive surgery.

Reconstructive surgeryprocedure

Reconstructive surgery is considered to be standard of care.

Questionnairesbehavioral

Questionnaire about pain, as well as participant's shoulder, arm, and hand range of motion completed at baseline, and at follow up visits 3-6.